Global Nasopharyngeal Airway Market
Global Nasopharyngeal Airway Market

Nasopharyngeal Airway Comprehensive Study by Type (Disposable, Reusable), Application (Operating Rooms, Emergency Care Departments, Intensive Care Units, Other), Distribution Channel (Online, Offline), End-User (Adult Patients, Pediatric Patients/Neonates) Players and Region - Global Market Outlook to 2025

Nasopharyngeal Airway Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Jun 2020 Edition 248 Pages 213 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
A nasopharyngeal airway is also known as an NPA, due to its flared end it is also called a nasal trumpet, or at times also known as a nasal tube, which is a type of airway accessory, it is basically a tube that is designed for the purpose of inserting into an open passage into the nasal passage. When a patient passes out, the muscles in the jaw usually relax and the tongue can slide back and clog the airways. This requires airway management and an NPA is one of the tools available. The purpose of the flared end is to prevent the device from being lost in the patient's nose. The growth of the market is mainly driven by the increasing spread of chronic respiratory diseases. Rising demand for emergency care; high incidence of premature birth; Investment, funding, and grants are growing through government agencies to improve emergency care infrastructure. The growing geriatric population and high prevalence of chronic diseases among adult patients are the main factors contributing to market growth. However, factors such as the harmful effects of certain devices on newborns, the lack of qualified specialists, and increasing price pressure on market participants have an adverse effect on the growth of the market.This growth is primarily driven by Rising Prevalence of Chronic Respiratory Diseases, Increasing Demand for Emergency Care and High Incidence of Preterm Births, The Rising Geriatric Population and The High Prevalence of Chronic Diseases in Adult Patients.

Globally, a noticeable market trend is evident Growth in Investments, Funds, and Grants by Government Bodies for Improving Emergency Care Infrastructure . Major Players, such as Teleflex/LMA (United States), Medtronic (Ireland), Ambu (Denmark), Intersurgical (United Kingdom), Carefusion (United States), Mercury Medical (United States), Wellead (China), ConvaTec Inc. (United Kingdom), Smiths Medical (United States), TUOREN (China), Medline (United States), IAWA (Austria), Medis (Slovenia) and Armstrong Medical Limited (United Kingdom) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Market Drivers
  • Rising Prevalence of Chronic Respiratory Diseases
  • Increasing Demand for Emergency Care and High Incidence of Preterm Births
  • The Rising Geriatric Population
  • The High Prevalence of Chronic Diseases in Adult Patients

Market Trend
  • Growth in Investments, Funds, and Grants by Government Bodies for Improving Emergency Care Infrastructure
  • The Availability of Highly Educated Physicians
  • The Increasing Number of Surgical Procedures Performed Where Airway Management Devices Are Used For Ventilation and Oxygenation

Restraints
  • Increasing Pricing Pressure on Market Players
  • Low Infrastructure and Treatment Costs

Opportunities
The Implementation of Favorable Government Initiatives and Growing Per Capita Income and Increasing Investments in the Healthcare Industry
Challenges
Harmful Effects of Certain Devices on Neonates and The Lack of Skilled Professionals

AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Disposable
  • Reusable
By Application
  • Operating Rooms
  • Emergency Care Departments
  • Intensive Care Units
  • Other
By Distribution Channel
  • Online
  • Offline

By End-User
  • Adult Patients
  • Pediatric Patients/Neonates

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Chronic Respiratory Diseases
      • 3.2.2. Increasing Demand for Emergency Care and High Incidence of Preterm Births
      • 3.2.3. The Rising Geriatric Population
      • 3.2.4. The High Prevalence of Chronic Diseases in Adult Patients
    • 3.3. Market Challenges
      • 3.3.1. Harmful Effects of Certain Devices on Neonates
      • 3.3.2. The Lack of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Growth in Investments, Funds, and Grants by Government Bodies for Improving Emergency Care Infrastructure
      • 3.4.2. The Availability of Highly Educated Physicians
      • 3.4.3. The Increasing Number of Surgical Procedures Performed Where Airway Management Devices Are Used For Ventilation and Oxygenation
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Nasopharyngeal Airway, by Type, Application, Distribution Channel, End-User and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Nasopharyngeal Airway (Value)
      • 5.2.1. Global Nasopharyngeal Airway by: Type (Value)
        • 5.2.1.1. Disposable
        • 5.2.1.2. Reusable
      • 5.2.2. Global Nasopharyngeal Airway by: Application (Value)
        • 5.2.2.1. Operating Rooms
        • 5.2.2.2. Emergency Care Departments
        • 5.2.2.3. Intensive Care Units
        • 5.2.2.4. Other
      • 5.2.3. Global Nasopharyngeal Airway by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Nasopharyngeal Airway by: End-User (Value)
        • 5.2.4.1. Adult Patients
        • 5.2.4.2. Pediatric Patients/Neonates
      • 5.2.5. Global Nasopharyngeal Airway Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Nasopharyngeal Airway (Volume)
      • 5.3.1. Global Nasopharyngeal Airway by: Type (Volume)
        • 5.3.1.1. Disposable
        • 5.3.1.2. Reusable
      • 5.3.2. Global Nasopharyngeal Airway by: Application (Volume)
        • 5.3.2.1. Operating Rooms
        • 5.3.2.2. Emergency Care Departments
        • 5.3.2.3. Intensive Care Units
        • 5.3.2.4. Other
      • 5.3.3. Global Nasopharyngeal Airway by: Distribution Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Offline
      • 5.3.4. Global Nasopharyngeal Airway by: End-User (Volume)
        • 5.3.4.1. Adult Patients
        • 5.3.4.2. Pediatric Patients/Neonates
      • 5.3.5. Global Nasopharyngeal Airway Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Nasopharyngeal Airway (Price)
      • 5.4.1. Global Nasopharyngeal Airway by: Type (Price)
  • 6. Nasopharyngeal Airway: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Teleflex/LMA (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ambu (Denmark)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Intersurgical (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Carefusion (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Mercury Medical (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Wellead (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ConvaTec Inc. (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Smiths Medical (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. TUOREN (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Medline (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. IAWA (Austria)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Medis (Slovenia)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Armstrong Medical Limited (United Kingdom)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Nasopharyngeal Airway Sale, by Type, Application, Distribution Channel, End-User and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Nasopharyngeal Airway (Value)
      • 7.2.1. Global Nasopharyngeal Airway by: Type (Value)
        • 7.2.1.1. Disposable
        • 7.2.1.2. Reusable
      • 7.2.2. Global Nasopharyngeal Airway by: Application (Value)
        • 7.2.2.1. Operating Rooms
        • 7.2.2.2. Emergency Care Departments
        • 7.2.2.3. Intensive Care Units
        • 7.2.2.4. Other
      • 7.2.3. Global Nasopharyngeal Airway by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Nasopharyngeal Airway by: End-User (Value)
        • 7.2.4.1. Adult Patients
        • 7.2.4.2. Pediatric Patients/Neonates
      • 7.2.5. Global Nasopharyngeal Airway Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Nasopharyngeal Airway (Volume)
      • 7.3.1. Global Nasopharyngeal Airway by: Type (Volume)
        • 7.3.1.1. Disposable
        • 7.3.1.2. Reusable
      • 7.3.2. Global Nasopharyngeal Airway by: Application (Volume)
        • 7.3.2.1. Operating Rooms
        • 7.3.2.2. Emergency Care Departments
        • 7.3.2.3. Intensive Care Units
        • 7.3.2.4. Other
      • 7.3.3. Global Nasopharyngeal Airway by: Distribution Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Offline
      • 7.3.4. Global Nasopharyngeal Airway by: End-User (Volume)
        • 7.3.4.1. Adult Patients
        • 7.3.4.2. Pediatric Patients/Neonates
      • 7.3.5. Global Nasopharyngeal Airway Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Nasopharyngeal Airway (Price)
      • 7.4.1. Global Nasopharyngeal Airway by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Nasopharyngeal Airway: by Type(USD Million)
  • Table 2. Nasopharyngeal Airway Disposable , by Region USD Million (2014-2019)
  • Table 3. Nasopharyngeal Airway Reusable , by Region USD Million (2014-2019)
  • Table 4. Nasopharyngeal Airway: by Application(USD Million)
  • Table 5. Nasopharyngeal Airway Operating Rooms , by Region USD Million (2014-2019)
  • Table 6. Nasopharyngeal Airway Emergency Care Departments , by Region USD Million (2014-2019)
  • Table 7. Nasopharyngeal Airway Intensive Care Units , by Region USD Million (2014-2019)
  • Table 8. Nasopharyngeal Airway Other , by Region USD Million (2014-2019)
  • Table 9. Nasopharyngeal Airway: by Distribution Channel(USD Million)
  • Table 10. Nasopharyngeal Airway Online , by Region USD Million (2014-2019)
  • Table 11. Nasopharyngeal Airway Offline , by Region USD Million (2014-2019)
  • Table 12. Nasopharyngeal Airway: by End-User(USD Million)
  • Table 13. Nasopharyngeal Airway Adult Patients , by Region USD Million (2014-2019)
  • Table 14. Nasopharyngeal Airway Pediatric Patients/Neonates , by Region USD Million (2014-2019)
  • Table 15. South America Nasopharyngeal Airway, by Country USD Million (2014-2019)
  • Table 16. South America Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 17. South America Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 18. South America Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 19. South America Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 20. Brazil Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 21. Brazil Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 22. Brazil Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 23. Brazil Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 24. Argentina Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 25. Argentina Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 26. Argentina Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 27. Argentina Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 28. Rest of South America Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 29. Rest of South America Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 30. Rest of South America Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 31. Rest of South America Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 32. Asia Pacific Nasopharyngeal Airway, by Country USD Million (2014-2019)
  • Table 33. Asia Pacific Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 34. Asia Pacific Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 35. Asia Pacific Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 36. Asia Pacific Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 37. China Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 38. China Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 39. China Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 40. China Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 41. Japan Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 42. Japan Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 43. Japan Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 44. Japan Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 45. India Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 46. India Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 47. India Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 48. India Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 49. South Korea Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 50. South Korea Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 51. South Korea Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 52. South Korea Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 53. Taiwan Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 54. Taiwan Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 55. Taiwan Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 56. Taiwan Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 57. Australia Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 58. Australia Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 59. Australia Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 60. Australia Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 61. Rest of Asia-Pacific Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 62. Rest of Asia-Pacific Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 63. Rest of Asia-Pacific Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 64. Rest of Asia-Pacific Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 65. Europe Nasopharyngeal Airway, by Country USD Million (2014-2019)
  • Table 66. Europe Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 67. Europe Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 68. Europe Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 69. Europe Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 70. Germany Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 71. Germany Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 72. Germany Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 73. Germany Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 74. France Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 75. France Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 76. France Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 77. France Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 78. Italy Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 79. Italy Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 80. Italy Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 81. Italy Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 82. United Kingdom Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 83. United Kingdom Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 84. United Kingdom Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 85. United Kingdom Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 86. Netherlands Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 87. Netherlands Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 88. Netherlands Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 89. Netherlands Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 90. Rest of Europe Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 91. Rest of Europe Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 92. Rest of Europe Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 93. Rest of Europe Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 94. MEA Nasopharyngeal Airway, by Country USD Million (2014-2019)
  • Table 95. MEA Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 96. MEA Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 97. MEA Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 98. MEA Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 99. Middle East Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 100. Middle East Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 101. Middle East Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 102. Middle East Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 103. Africa Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 104. Africa Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 105. Africa Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 106. Africa Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 107. North America Nasopharyngeal Airway, by Country USD Million (2014-2019)
  • Table 108. North America Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 109. North America Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 110. North America Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 111. North America Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 112. United States Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 113. United States Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 114. United States Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 115. United States Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 116. Canada Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 117. Canada Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 118. Canada Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 119. Canada Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 120. Mexico Nasopharyngeal Airway, by Type USD Million (2014-2019)
  • Table 121. Mexico Nasopharyngeal Airway, by Application USD Million (2014-2019)
  • Table 122. Mexico Nasopharyngeal Airway, by Distribution Channel USD Million (2014-2019)
  • Table 123. Mexico Nasopharyngeal Airway, by End-User USD Million (2014-2019)
  • Table 124. Nasopharyngeal Airway Sales: by Type(K Units)
  • Table 125. Nasopharyngeal Airway Sales Disposable , by Region K Units (2014-2019)
  • Table 126. Nasopharyngeal Airway Sales Reusable , by Region K Units (2014-2019)
  • Table 127. Nasopharyngeal Airway Sales: by Application(K Units)
  • Table 128. Nasopharyngeal Airway Sales Operating Rooms , by Region K Units (2014-2019)
  • Table 129. Nasopharyngeal Airway Sales Emergency Care Departments , by Region K Units (2014-2019)
  • Table 130. Nasopharyngeal Airway Sales Intensive Care Units , by Region K Units (2014-2019)
  • Table 131. Nasopharyngeal Airway Sales Other , by Region K Units (2014-2019)
  • Table 132. Nasopharyngeal Airway Sales: by Distribution Channel(K Units)
  • Table 133. Nasopharyngeal Airway Sales Online , by Region K Units (2014-2019)
  • Table 134. Nasopharyngeal Airway Sales Offline , by Region K Units (2014-2019)
  • Table 135. Nasopharyngeal Airway Sales: by End-User(K Units)
  • Table 136. Nasopharyngeal Airway Sales Adult Patients , by Region K Units (2014-2019)
  • Table 137. Nasopharyngeal Airway Sales Pediatric Patients/Neonates , by Region K Units (2014-2019)
  • Table 138. South America Nasopharyngeal Airway Sales, by Country K Units (2014-2019)
  • Table 139. South America Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 140. South America Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 141. South America Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 142. South America Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 143. Brazil Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 144. Brazil Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 145. Brazil Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 146. Brazil Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 147. Argentina Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 148. Argentina Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 149. Argentina Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 150. Argentina Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 151. Rest of South America Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 152. Rest of South America Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 153. Rest of South America Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 154. Rest of South America Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 155. Asia Pacific Nasopharyngeal Airway Sales, by Country K Units (2014-2019)
  • Table 156. Asia Pacific Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 157. Asia Pacific Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 158. Asia Pacific Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 159. Asia Pacific Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 160. China Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 161. China Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 162. China Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 163. China Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 164. Japan Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 165. Japan Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 166. Japan Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 167. Japan Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 168. India Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 169. India Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 170. India Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 171. India Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 172. South Korea Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 173. South Korea Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 174. South Korea Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 175. South Korea Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 176. Taiwan Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 177. Taiwan Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 178. Taiwan Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 179. Taiwan Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 180. Australia Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 181. Australia Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 182. Australia Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 183. Australia Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 184. Rest of Asia-Pacific Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 185. Rest of Asia-Pacific Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 186. Rest of Asia-Pacific Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 187. Rest of Asia-Pacific Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 188. Europe Nasopharyngeal Airway Sales, by Country K Units (2014-2019)
  • Table 189. Europe Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 190. Europe Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 191. Europe Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 192. Europe Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 193. Germany Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 194. Germany Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 195. Germany Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 196. Germany Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 197. France Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 198. France Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 199. France Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 200. France Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 201. Italy Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 202. Italy Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 203. Italy Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 204. Italy Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 205. United Kingdom Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 206. United Kingdom Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 207. United Kingdom Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 208. United Kingdom Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 209. Netherlands Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 210. Netherlands Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 211. Netherlands Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 212. Netherlands Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 213. Rest of Europe Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 214. Rest of Europe Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 215. Rest of Europe Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 216. Rest of Europe Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 217. MEA Nasopharyngeal Airway Sales, by Country K Units (2014-2019)
  • Table 218. MEA Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 219. MEA Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 220. MEA Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 221. MEA Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 222. Middle East Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 223. Middle East Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 224. Middle East Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 225. Middle East Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 226. Africa Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 227. Africa Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 228. Africa Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 229. Africa Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 230. North America Nasopharyngeal Airway Sales, by Country K Units (2014-2019)
  • Table 231. North America Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 232. North America Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 233. North America Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 234. North America Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 235. United States Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 236. United States Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 237. United States Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 238. United States Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 239. Canada Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 240. Canada Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 241. Canada Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 242. Canada Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 243. Mexico Nasopharyngeal Airway Sales, by Type K Units (2014-2019)
  • Table 244. Mexico Nasopharyngeal Airway Sales, by Application K Units (2014-2019)
  • Table 245. Mexico Nasopharyngeal Airway Sales, by Distribution Channel K Units (2014-2019)
  • Table 246. Mexico Nasopharyngeal Airway Sales, by End-User K Units (2014-2019)
  • Table 247. Nasopharyngeal Airway: by Type(USD/Units)
  • Table 248. Company Basic Information, Sales Area and Its Competitors
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Nasopharyngeal Airway: by Type(USD Million)
  • Table 263. Nasopharyngeal Airway Disposable , by Region USD Million (2020-2025)
  • Table 264. Nasopharyngeal Airway Reusable , by Region USD Million (2020-2025)
  • Table 265. Nasopharyngeal Airway: by Application(USD Million)
  • Table 266. Nasopharyngeal Airway Operating Rooms , by Region USD Million (2020-2025)
  • Table 267. Nasopharyngeal Airway Emergency Care Departments , by Region USD Million (2020-2025)
  • Table 268. Nasopharyngeal Airway Intensive Care Units , by Region USD Million (2020-2025)
  • Table 269. Nasopharyngeal Airway Other , by Region USD Million (2020-2025)
  • Table 270. Nasopharyngeal Airway: by Distribution Channel(USD Million)
  • Table 271. Nasopharyngeal Airway Online , by Region USD Million (2020-2025)
  • Table 272. Nasopharyngeal Airway Offline , by Region USD Million (2020-2025)
  • Table 273. Nasopharyngeal Airway: by End-User(USD Million)
  • Table 274. Nasopharyngeal Airway Adult Patients , by Region USD Million (2020-2025)
  • Table 275. Nasopharyngeal Airway Pediatric Patients/Neonates , by Region USD Million (2020-2025)
  • Table 276. South America Nasopharyngeal Airway, by Country USD Million (2020-2025)
  • Table 277. South America Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 278. South America Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 279. South America Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 280. South America Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 281. Brazil Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 282. Brazil Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 283. Brazil Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 284. Brazil Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 285. Argentina Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 286. Argentina Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 287. Argentina Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 288. Argentina Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 289. Rest of South America Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 290. Rest of South America Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 291. Rest of South America Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 292. Rest of South America Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 293. Asia Pacific Nasopharyngeal Airway, by Country USD Million (2020-2025)
  • Table 294. Asia Pacific Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 295. Asia Pacific Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 296. Asia Pacific Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 297. Asia Pacific Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 298. China Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 299. China Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 300. China Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 301. China Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 302. Japan Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 303. Japan Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 304. Japan Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 305. Japan Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 306. India Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 307. India Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 308. India Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 309. India Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 310. South Korea Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 311. South Korea Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 312. South Korea Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 313. South Korea Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 314. Taiwan Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 315. Taiwan Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 316. Taiwan Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 317. Taiwan Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 318. Australia Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 319. Australia Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 320. Australia Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 321. Australia Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 322. Rest of Asia-Pacific Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 323. Rest of Asia-Pacific Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 324. Rest of Asia-Pacific Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 325. Rest of Asia-Pacific Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 326. Europe Nasopharyngeal Airway, by Country USD Million (2020-2025)
  • Table 327. Europe Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 328. Europe Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 329. Europe Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 330. Europe Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 331. Germany Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 332. Germany Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 333. Germany Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 334. Germany Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 335. France Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 336. France Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 337. France Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 338. France Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 339. Italy Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 340. Italy Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 341. Italy Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 342. Italy Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 343. United Kingdom Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 344. United Kingdom Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 345. United Kingdom Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 346. United Kingdom Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 347. Netherlands Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 348. Netherlands Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 349. Netherlands Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 350. Netherlands Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 351. Rest of Europe Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 352. Rest of Europe Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 353. Rest of Europe Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 354. Rest of Europe Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 355. MEA Nasopharyngeal Airway, by Country USD Million (2020-2025)
  • Table 356. MEA Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 357. MEA Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 358. MEA Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 359. MEA Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 360. Middle East Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 361. Middle East Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 362. Middle East Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 363. Middle East Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 364. Africa Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 365. Africa Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 366. Africa Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 367. Africa Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 368. North America Nasopharyngeal Airway, by Country USD Million (2020-2025)
  • Table 369. North America Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 370. North America Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 371. North America Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 372. North America Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 373. United States Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 374. United States Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 375. United States Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 376. United States Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 377. Canada Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 378. Canada Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 379. Canada Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 380. Canada Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 381. Mexico Nasopharyngeal Airway, by Type USD Million (2020-2025)
  • Table 382. Mexico Nasopharyngeal Airway, by Application USD Million (2020-2025)
  • Table 383. Mexico Nasopharyngeal Airway, by Distribution Channel USD Million (2020-2025)
  • Table 384. Mexico Nasopharyngeal Airway, by End-User USD Million (2020-2025)
  • Table 385. Nasopharyngeal Airway Sales: by Type(K Units)
  • Table 386. Nasopharyngeal Airway Sales Disposable , by Region K Units (2020-2025)
  • Table 387. Nasopharyngeal Airway Sales Reusable , by Region K Units (2020-2025)
  • Table 388. Nasopharyngeal Airway Sales: by Application(K Units)
  • Table 389. Nasopharyngeal Airway Sales Operating Rooms , by Region K Units (2020-2025)
  • Table 390. Nasopharyngeal Airway Sales Emergency Care Departments , by Region K Units (2020-2025)
  • Table 391. Nasopharyngeal Airway Sales Intensive Care Units , by Region K Units (2020-2025)
  • Table 392. Nasopharyngeal Airway Sales Other , by Region K Units (2020-2025)
  • Table 393. Nasopharyngeal Airway Sales: by Distribution Channel(K Units)
  • Table 394. Nasopharyngeal Airway Sales Online , by Region K Units (2020-2025)
  • Table 395. Nasopharyngeal Airway Sales Offline , by Region K Units (2020-2025)
  • Table 396. Nasopharyngeal Airway Sales: by End-User(K Units)
  • Table 397. Nasopharyngeal Airway Sales Adult Patients , by Region K Units (2020-2025)
  • Table 398. Nasopharyngeal Airway Sales Pediatric Patients/Neonates , by Region K Units (2020-2025)
  • Table 399. South America Nasopharyngeal Airway Sales, by Country K Units (2020-2025)
  • Table 400. South America Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 401. South America Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 402. South America Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 403. South America Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 404. Brazil Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 405. Brazil Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 406. Brazil Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 407. Brazil Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 408. Argentina Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 409. Argentina Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 410. Argentina Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 411. Argentina Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 412. Rest of South America Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 413. Rest of South America Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 414. Rest of South America Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 415. Rest of South America Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 416. Asia Pacific Nasopharyngeal Airway Sales, by Country K Units (2020-2025)
  • Table 417. Asia Pacific Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 418. Asia Pacific Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 419. Asia Pacific Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 420. Asia Pacific Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 421. China Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 422. China Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 423. China Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 424. China Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 425. Japan Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 426. Japan Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 427. Japan Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 428. Japan Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 429. India Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 430. India Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 431. India Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 432. India Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 433. South Korea Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 434. South Korea Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 435. South Korea Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 436. South Korea Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 437. Taiwan Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 438. Taiwan Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 439. Taiwan Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 440. Taiwan Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 441. Australia Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 442. Australia Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 443. Australia Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 444. Australia Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 445. Rest of Asia-Pacific Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 446. Rest of Asia-Pacific Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 447. Rest of Asia-Pacific Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 448. Rest of Asia-Pacific Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 449. Europe Nasopharyngeal Airway Sales, by Country K Units (2020-2025)
  • Table 450. Europe Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 451. Europe Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 452. Europe Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 453. Europe Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 454. Germany Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 455. Germany Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 456. Germany Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 457. Germany Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 458. France Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 459. France Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 460. France Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 461. France Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 462. Italy Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 463. Italy Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 464. Italy Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 465. Italy Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 466. United Kingdom Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 467. United Kingdom Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 468. United Kingdom Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 469. United Kingdom Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 470. Netherlands Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 471. Netherlands Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 472. Netherlands Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 473. Netherlands Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 474. Rest of Europe Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 475. Rest of Europe Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 476. Rest of Europe Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 477. Rest of Europe Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 478. MEA Nasopharyngeal Airway Sales, by Country K Units (2020-2025)
  • Table 479. MEA Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 480. MEA Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 481. MEA Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 482. MEA Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 483. Middle East Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 484. Middle East Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 485. Middle East Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 486. Middle East Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 487. Africa Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 488. Africa Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 489. Africa Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 490. Africa Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 491. North America Nasopharyngeal Airway Sales, by Country K Units (2020-2025)
  • Table 492. North America Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 493. North America Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 494. North America Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 495. North America Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 496. United States Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 497. United States Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 498. United States Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 499. United States Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 500. Canada Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 501. Canada Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 502. Canada Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 503. Canada Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 504. Mexico Nasopharyngeal Airway Sales, by Type K Units (2020-2025)
  • Table 505. Mexico Nasopharyngeal Airway Sales, by Application K Units (2020-2025)
  • Table 506. Mexico Nasopharyngeal Airway Sales, by Distribution Channel K Units (2020-2025)
  • Table 507. Mexico Nasopharyngeal Airway Sales, by End-User K Units (2020-2025)
  • Table 508. Nasopharyngeal Airway: by Type(USD/Units)
  • Table 509. Research Programs/Design for This Report
  • Table 510. Key Data Information from Secondary Sources
  • Table 511. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Nasopharyngeal Airway: by Type USD Million (2014-2019)
  • Figure 5. Global Nasopharyngeal Airway: by Application USD Million (2014-2019)
  • Figure 6. Global Nasopharyngeal Airway: by Distribution Channel USD Million (2014-2019)
  • Figure 7. Global Nasopharyngeal Airway: by End-User USD Million (2014-2019)
  • Figure 8. South America Nasopharyngeal Airway Share (%), by Country
  • Figure 9. Asia Pacific Nasopharyngeal Airway Share (%), by Country
  • Figure 10. Europe Nasopharyngeal Airway Share (%), by Country
  • Figure 11. MEA Nasopharyngeal Airway Share (%), by Country
  • Figure 12. North America Nasopharyngeal Airway Share (%), by Country
  • Figure 13. Global Nasopharyngeal Airway: by Type K Units (2014-2019)
  • Figure 14. Global Nasopharyngeal Airway: by Application K Units (2014-2019)
  • Figure 15. Global Nasopharyngeal Airway: by Distribution Channel K Units (2014-2019)
  • Figure 16. Global Nasopharyngeal Airway: by End-User K Units (2014-2019)
  • Figure 17. South America Nasopharyngeal Airway Share (%), by Country
  • Figure 18. Asia Pacific Nasopharyngeal Airway Share (%), by Country
  • Figure 19. Europe Nasopharyngeal Airway Share (%), by Country
  • Figure 20. MEA Nasopharyngeal Airway Share (%), by Country
  • Figure 21. North America Nasopharyngeal Airway Share (%), by Country
  • Figure 22. Global Nasopharyngeal Airway: by Type USD/Units (2014-2019)
  • Figure 23. Global Nasopharyngeal Airway share by Players 2019 (%)
  • Figure 24. Global Nasopharyngeal Airway share by Players (Top 3) 2019(%)
  • Figure 25. Global Nasopharyngeal Airway share by Players (Top 5) 2019(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Teleflex/LMA (United States) Revenue, Net Income and Gross profit
  • Figure 28. Teleflex/LMA (United States) Revenue: by Geography 2019
  • Figure 29. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. Medtronic (Ireland) Revenue: by Geography 2019
  • Figure 31. Ambu (Denmark) Revenue, Net Income and Gross profit
  • Figure 32. Ambu (Denmark) Revenue: by Geography 2019
  • Figure 33. Intersurgical (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Intersurgical (United Kingdom) Revenue: by Geography 2019
  • Figure 35. Carefusion (United States) Revenue, Net Income and Gross profit
  • Figure 36. Carefusion (United States) Revenue: by Geography 2019
  • Figure 37. Mercury Medical (United States) Revenue, Net Income and Gross profit
  • Figure 38. Mercury Medical (United States) Revenue: by Geography 2019
  • Figure 39. Wellead (China) Revenue, Net Income and Gross profit
  • Figure 40. Wellead (China) Revenue: by Geography 2019
  • Figure 41. ConvaTec Inc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 42. ConvaTec Inc. (United Kingdom) Revenue: by Geography 2019
  • Figure 43. Smiths Medical (United States) Revenue, Net Income and Gross profit
  • Figure 44. Smiths Medical (United States) Revenue: by Geography 2019
  • Figure 45. TUOREN (China) Revenue, Net Income and Gross profit
  • Figure 46. TUOREN (China) Revenue: by Geography 2019
  • Figure 47. Medline (United States) Revenue, Net Income and Gross profit
  • Figure 48. Medline (United States) Revenue: by Geography 2019
  • Figure 49. IAWA (Austria) Revenue, Net Income and Gross profit
  • Figure 50. IAWA (Austria) Revenue: by Geography 2019
  • Figure 51. Medis (Slovenia) Revenue, Net Income and Gross profit
  • Figure 52. Medis (Slovenia) Revenue: by Geography 2019
  • Figure 53. Armstrong Medical Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 54. Armstrong Medical Limited (United Kingdom) Revenue: by Geography 2019
  • Figure 55. Global Nasopharyngeal Airway: by Type USD Million (2020-2025)
  • Figure 56. Global Nasopharyngeal Airway: by Application USD Million (2020-2025)
  • Figure 57. Global Nasopharyngeal Airway: by Distribution Channel USD Million (2020-2025)
  • Figure 58. Global Nasopharyngeal Airway: by End-User USD Million (2020-2025)
  • Figure 59. South America Nasopharyngeal Airway Share (%), by Country
  • Figure 60. Asia Pacific Nasopharyngeal Airway Share (%), by Country
  • Figure 61. Europe Nasopharyngeal Airway Share (%), by Country
  • Figure 62. MEA Nasopharyngeal Airway Share (%), by Country
  • Figure 63. North America Nasopharyngeal Airway Share (%), by Country
  • Figure 64. Global Nasopharyngeal Airway: by Type K Units (2020-2025)
  • Figure 65. Global Nasopharyngeal Airway: by Application K Units (2020-2025)
  • Figure 66. Global Nasopharyngeal Airway: by Distribution Channel K Units (2020-2025)
  • Figure 67. Global Nasopharyngeal Airway: by End-User K Units (2020-2025)
  • Figure 68. South America Nasopharyngeal Airway Share (%), by Country
  • Figure 69. Asia Pacific Nasopharyngeal Airway Share (%), by Country
  • Figure 70. Europe Nasopharyngeal Airway Share (%), by Country
  • Figure 71. MEA Nasopharyngeal Airway Share (%), by Country
  • Figure 72. North America Nasopharyngeal Airway Share (%), by Country
  • Figure 73. Global Nasopharyngeal Airway: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • Teleflex/LMA (United States)
  • Medtronic (Ireland)
  • Ambu (Denmark)
  • Intersurgical (United Kingdom)
  • Carefusion (United States)
  • Mercury Medical (United States)
  • Wellead (China)
  • ConvaTec Inc. (United Kingdom)
  • Smiths Medical (United States)
  • TUOREN (China)
  • Medline (United States)
  • IAWA (Austria)
  • Medis (Slovenia)
  • Armstrong Medical Limited (United Kingdom)
Additional players considered in the study are as follows:
Zhejiang Sujia (China) , Songhang (Vietnam)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation